Robecosam AG decreased its position in shares of Cerner Co. (NASDAQ:CERN) by 3.1% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 197,529 shares of the company’s stock after selling 6,361 shares during the period. Robecosam AG owned 0.06% of Cerner worth $13,418,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. lifted its stake in shares of Cerner by 2.2% during the fourth quarter. BlackRock Inc. now owns 19,519,304 shares of the company’s stock valued at $1,315,406,000 after buying an additional 420,942 shares during the period. Capital International Investors raised its stake in Cerner by 0.3% during the third quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock worth $345,994,000 after purchasing an additional 12,178 shares during the period. Geode Capital Management LLC raised its stake in Cerner by 2.7% during the fourth quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock worth $252,916,000 after purchasing an additional 98,444 shares during the period. American Century Companies Inc. raised its stake in Cerner by 3.7% during the fourth quarter. American Century Companies Inc. now owns 3,204,461 shares of the company’s stock worth $215,949,000 after purchasing an additional 114,224 shares during the period. Finally, Legal & General Group Plc raised its stake in Cerner by 1.8% during the third quarter. Legal & General Group Plc now owns 1,477,451 shares of the company’s stock worth $105,371,000 after purchasing an additional 25,842 shares during the period. 78.56% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have weighed in on CERN shares. Zacks Investment Research raised shares of Cerner from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a research note on Tuesday, January 9th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $70.00 price target on shares of Cerner in a research note on Thursday, November 30th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $75.00 price target on shares of Cerner in a research note on Wednesday, November 29th. Royal Bank of Canada reaffirmed a “buy” rating and set a $74.00 price target on shares of Cerner in a research note on Wednesday, November 22nd. Finally, Robert W. Baird reaffirmed a “buy” rating on shares of Cerner in a research note on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and nine have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $67.66.
Cerner Co. (CERN) opened at $64.91 on Monday. Cerner Co. has a one year low of $54.49 and a one year high of $73.86. The company has a quick ratio of 2.99, a current ratio of 3.01 and a debt-to-equity ratio of 0.11. The company has a market cap of $21,588.89, a price-to-earnings ratio of 29.24, a PEG ratio of 1.89 and a beta of 0.93.
Cerner (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. Cerner’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.61 earnings per share. sell-side analysts forecast that Cerner Co. will post 2.42 earnings per share for the current year.
WARNING: “Cerner Co. (CERN) Position Lessened by Robecosam AG” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/12/cerner-co-cern-position-lessened-by-robecosam-ag.html.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.